Blue Trust’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.2K Sell
150
-37
-20% -$1.35K ﹤0.01% 1844
2026
Q2
$7.38K Buy
+187
New +$7.54K ﹤0.01% 1939

Other funds holding MDLN

Blue Trust's MDLN Position: Q3 2026 in Review

Blue Trust reduced its Medline (MDLN) stake by 20% in Q3 2026, selling an estimated $1.35K and leaving 150 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Blue Trust first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $7.38K in Q2 2026. 331 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Blue Trust held 150 shares of Medline worth $5.2K as of Q3 2026.
  • Blue Trust sold 37 Medline shares in Q3 2026, an estimated $1.35K.
  • Medline made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1844 holding.
  • Blue Trust first reported a position in Medline in Q2 2026 and has held it in 2 quarters since.
  • Blue Trust's Medline position peaked at $7.38K in Q2 2026.
  • 331 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.